Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted therapeutics for severe refractory asthma: monoclonal antibodies.

Expert review of clinical pharmacology - 1 Jul 2016

Grainge Christopher L, Maltby Steven, Gibson Peter G, Wark Peter A B, McDonald Vanessa M

Abstract excerpt

Severe asthma is a complex multifactorial disease that requires specialist multidisciplinary input for optimal clinical outcomes. Following multidimensional assessment for optimisation of current therapy, self-management skills and comorbidities, all patients should be accurately phenotyped. Only after this assessment has been completed should new monoclonal antibody therapies be considered. In this review, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Asthmatic Agents
Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Asthma

Share to Molecular Targeted Therapy

Share to Phenotype

Share to Severity of Illness Index

Source

Identifiers

PMID: 27018798
DOI: 10.1586/17512433.2016.1172208

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted therapeutics for severe refractory asthma: monoclonal antibodies.PMID 27018798Read ↗

Biologics in severe asthma: A pragmatic approach for choosing the right treatment for the right patient.Semantic proximity Read ↗

Biologics in severe asthma: the overlap endotype - opportunities and challenges.Semantic proximity Read ↗

Moving toward consensus on diagnosis and management of severe asthma in adults.Semantic proximity Read ↗

Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.Semantic proximity Read ↗

Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes.Semantic proximity Read ↗

Current concepts of severe asthma.Semantic proximity Read ↗

Severe refractory asthma: an update.Semantic proximity Read ↗

Diagnosis and treatment of severe asthma: a phenotype-based approach.Semantic proximity Read ↗

Future treatment for asthma.Semantic proximity Read ↗

New approaches for identifying and testing potential new anti-asthma agents.Semantic proximity Read ↗

Managing severe asthma in adults: lessons from the ERS/ATS guidelines.Semantic proximity Read ↗

Asthma Phenotypes in the Era of Personalized MedicineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.